Altria Customer Services has submitted multiple patent applications related to vaping technology to the United States Patent and Trademark Office, including several that mention CBD and nicotine.
Credit goes to New Africa.
On August 4th, the company released three relevant applications, specifically focusing on CBD plants and their "flavor and aroma characteristics.
Altria Customer Service and the Virginia University Patent Foundation have submitted an application titled "Plant Terpene Production", which provides a detailed explanation of "ingredients and methods for altering the secondary metabolism functions of tobacco or CBD plant glandular trichomes, which control the formation of terpenes that impart specific flavors and aromatic characteristics to plant leaves." The piney or citrusy scent and flavor of cannabis buds are typical examples of terpene aromas.
The application stated that "by selectively manipulating gene expression in the terpene biosynthesis pathway, it is possible to enhance and modify the terpene levels in tobacco and CBD plants, improving the taste and aroma characteristics of downstream plant products.
The application stated that a related application titled "Increasing Trichome Density and Improving Metabolite Transport in Plant Trichomes...Terpenoid Plants are the Largest and Most Diverse Class of Plant Metabolites.
It further stated that, "The quantity of secondary metabolites produced is generally closely related to the density of glandular trichomes on the plant surface." "One method to increase the production of plant secondary metabolites is by increasing the density of trichomes on the plant epidermis.
The title of the third relevant application is "Promoters of Specific Tissues in Plants". According to the application, "Identification of preferred or specific trimeric promoters and corresponding cis-regulatory elements is required due to the important role of glandular trichomes in the biosynthesis and secretion of terpenoids.
In summary, these patent applications provide the clearest indication to date of Altria's interests and priorities in future CBD products. Altria acquired a significant stake in Canadian CBD company Cronos in 2019.
Statement:
This article is compiled from third-party information and is intended solely for industry exchange and learning purposes.
This article does not reflect the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity and accuracy of the contents of the article. The compilation of this article is solely intended for industry communication and research.
Due to the limitations of the translator's ability, the translated article may not express the same meaning as the original. Therefore, readers should refer to the original article for accuracy.
2FIRSTS maintains full alignment with the Chinese government regarding any domestic, Hong Kong, Taiwan, or foreign-related statements and positions.
The compilation and distribution of this information is the property of the original media and its authors. If there is any infringement, please contact us for removal.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
